Table of contents
November 2005 Vol 4 No 11
In this issue
p867 | doi:10.1038/nrd1899
Editorial: Setting New Standards
p869 | doi:10.1038/nrd1898
News and Analysis
Many issues in store for new FDA commissioner | PDF (99 KB)
p871 | doi:10.1038/nrd1894
Royal Society puts personalized medicine in perspective | PDF (118 KB)
p872 | doi:10.1038/nrd1895
Study shows newer schizophrenia treatments no more effective than old | PDF (132 KB)
p872 | doi:10.1038/nrd1896
News in Brief
Patent watch
Lipitor scope upheld but second patent invalid | PDF (71 KB)
p876 | doi:10.1038/nrd1889
Patent watch
You say lactic acid, I say lactide | PDF (63 KB)
p876 | doi:10.1038/nrd1890
Patent watch
Genentech calm Cabilly storm | PDF (59 KB)
p876 | doi:10.1038/nrd1891
Patent primer
Priority patent applications | PDF (57 KB)
p877 | doi:10.1038/nrd1882
An Audience With
Victoria G. Hale | PDF (89 KB)
p878 | doi:10.1038/nrd1897
From the analyst's couch
TLR-targeted therapeutics | PDF (135 KB)
p879 | doi:10.1038/nrd1880
Fresh from the Pipeline
Ramelteon | PDF (154 KB)
p881 | doi:10.1038/nrd1881
Research Highlights
Atherosclerosis: Go with the flow | PDF (347 KB)
p883 | doi:10.1038/nrd1886
Analgesics: New clues in the acetaminophen mystery | PDF (158 KB)
p883 | doi:10.1038/nrd1887
Biotechnology: Human antibodies from chicken eggs | PDF (526 KB)
p884 | doi:10.1038/nrd1883
Antifungal drugs: A helping hand | PDF (240 KB)
p884 | doi:10.1038/nrd1885
In brief
Diabetes | Ageing | Biotechnology | Gene therapy | PDF (180 KB)
p886 | doi:10.1038/nrd1884
Infectious disease: Emptying reservoirs of latent HIV-1 | PDF (180 KB)
p886 | doi:10.1038/nrd1888
Perspectives
Outlook
The profit problem in antibiotic R&D
Carl Nathan & Frederick M. Goldberg
p887 | doi:10.1038/nrd1878
Outlook
Finding improved medicines: the role of academic–industrial collaboration
Jaye Chin-Dusting, Jacques Mizrahi, Garry Jennings & Desmond Fitzgerald
p891 | doi:10.1038/nrd1879
Reviews
Drug therapy for atrial fibrillation: where do we go from here?
Richard L. Page & Dan M. Roden
p899 | doi:10.1038/nrd1876
Combinatorial Pharmacogenetics
Russell A. Wilke, David M. Reif & Jason H. Moore
p911 | doi:10.1038/nrd1874
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Terry Kenakin
p919 | doi:10.1038/nrd1875
Case history
Acyclic nucleoside phosphonates: a key class of antiviral drugs
Erik De Clercq & Antonín Holý
p928 | doi:10.1038/nrd1877
